Federica Maccarinelli
Overview
Explore the profile of Federica Maccarinelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
590
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moreno A, Canziani S, Lelli D, Castelli A, Bianchi A, Bertoletti I, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675932
In this study, virological surveillance focused on coronaviruses in marmots in the Alpine region in 2022, captured as part of a population control reduction program in the Livigno area. Seventy-six...
2.
dAmati A, Ronca R, Maccarinelli F, Turati M, Lorusso L, De Giorgis M, et al.
Pathol Res Pract
. 2023 Nov;
251:154901.
PMID: 37922722
The long pentraxin 3 (PTX3) is protective in different pathologies but was not analyzed in-depth in Idiopathic Pulmonary Fibrosis (IPF). Here, we have explored the influence of PTX3 in the...
3.
Giacomini A, Turati M, Grillo E, Rezzola S, Ghedini G, Schuind A, et al.
Exp Hematol Oncol
. 2023 Sep;
12(1):82.
PMID: 37749607
Background: The pattern recognition receptor long pentraxin-3 (PTX3) plays conflicting roles in cancer by acting as an oncosuppressor or as a pro-tumor mediator depending on tumor context. Triple negative breast...
4.
Maccarinelli F, Coltrini D, Mussi S, Bugatti M, Turati M, Chiodelli P, et al.
Cell Death Discov
. 2023 Mar;
9(1):81.
PMID: 36872341
Prostate cancer (PCa) is a leading cause of death in the male population commonly treated with androgen deprivation therapy that often relapses as androgen-independent and aggressive castration-resistant prostate cancer (CRPC)....
5.
Mahmoud A, Kostrzewa M, Marolda V, Cerasuolo M, Maccarinelli F, Coltrini D, et al.
Pharmacol Res
. 2023 Feb;
189:106683.
PMID: 36736415
In spite of the huge advancements in both diagnosis and interventions, hormone refractory prostate cancer (HRPC) remains a major hurdle in prostate cancer (PCa). Metabolic reprogramming plays a key role...
6.
Turati M, Giacomini A, Rezzola S, Maccarinelli F, Gazzaroli G, Valentino S, et al.
Exp Hematol Oncol
. 2022 Nov;
11(1):84.
PMID: 36320051
The lymphatic vascular system represents a major route for dissemination of several solid tumors, including melanoma. Even though the members of the Vascular Endothelial Growth Factor family VEGF-C and VEGF-A...
7.
Chiodelli P, Coltrini D, Turati M, Cerasuolo M, Maccarinelli F, Rezzola S, et al.
Cancer Lett
. 2021 Dec;
526:217-224.
PMID: 34861311
Prostate cancer (PCa) is a leading cause of cancer mortality in the male population commonly treated with androgen deprivation therapy (ADT) and relapsing as aggressive and androgen-independent castration-resistant prostate cancer...
8.
Sacco A, Federico C, Todoerti K, Ziccheddu B, Palermo V, Giacomini A, et al.
Blood
. 2021 Jun;
138(18):1705-1720.
PMID: 34077955
Alterations in KRAS have been identified as the most recurring somatic variants in the multiple myeloma (MM) mutational landscape. Combining DNA and RNA sequencing, we studied 756 patients and observed...
9.
Asperti M, Bellini S, Grillo E, Gryzik M, Cantamessa L, Ronca R, et al.
Free Radic Biol Med
. 2021 Apr;
169:294-303.
PMID: 33892112
Ferroptosis is a form of regulated cell death dependent on iron, reactive oxygen species and characterized by the accumulation of lipid peroxides. It can be experimentally initiated by chemicals, such...
10.
Maccarinelli F, Bugatti M, Schuind A, Ganzerla S, Vermi W, Presta M, et al.
Front Immunol
. 2021 Mar;
12:617671.
PMID: 33679758
Pulmonary fibrosis is a progressive scarring disease of the lungs, characterized by inflammation, fibroblast activation, and deposition of extracellular matrix. The long pentraxin 3 (PTX3) is a member of the...